Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Cozzi

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Cell Death & Disease|October 3, 2014
PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathwaysL Chang, P H Graham, J Hao, et al.
British Journal of Cancer|August 26, 2010
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progressionJ Hao, H Chen, M C Madigan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 10, 2001
Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic modelP J Cozzi, S Malhotra, P McAuliffe, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2004
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancerP J Russell, K T Ow, P N Tam, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Cell Death & Disease|October 3, 2014
PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathwaysL Chang, P H Graham, J Hao, et al.
British Journal of Cancer|August 26, 2010
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progressionJ Hao, H Chen, M C Madigan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 10, 2001
Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic modelP J Cozzi, S Malhotra, P McAuliffe, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2004
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancerP J Russell, K T Ow, P N Tam, et al.
Pageof 4